Myeloproliferative neoplasms cause glomerulopathy

Kidney International

Volumn 80, Issue 7, 2011, Pages 753-759

  Said, Samar M ^a   Leung, Nelson ^a   Sethi, Sanjeev ^a   Cornell, Lynn D ^a   Fidler, Mary E ^a   Grande, Joseph P ^a   Herrmann, Sandra ^a   Tefferi, Ayalew ^a   D'Agati, Vivette D ^b   Nasr, Samih H ^a  

^a MAYO CLINIC   (United States)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

glomerulopathy; glomerulosclerosis; pathology; proteinuria

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULOPATHY; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MALE; MESANGIAL SCLEROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; THROMBOCYTHEMIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 80052832234     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.147     Document Type: Article

References (38)

1. Swerdlow SH, Campo E, Harris NL et al. (eds) WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008.
2. Schnuelle P, Waldherr R, Lehmann KJ et al. Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidneys. Clin Nephrol 1999; 52: 256-262. (Pubitemid 29467102)
3. Bello Nicolau I, Conde Zurita JM, Barrientos Guzman A et al. Essential thrombocytosis with acute renal failure due to bilateral thrombosis of the renal arteries and veins. Nephron 1982; 32: 73-74. (Pubitemid 12006089)
4. Votaw ML, Spannuth Jr C, Krish G et al. Acute renal failure in a patient with essential thrombocythemia, diabetes mellitus, and heterozygous hemoglobin C disease. South Med J 1990; 83: 57-59. (Pubitemid 20049627)
5. Al-Kali A, Farooq S, Tfayli A. Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia. J Clin Pharm Ther 2009; 34: 607-610.
6. Yuzawa Y, Sato W, Masuda T et al. Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia. Intern Med 2010; 49: 1139-1142.
7. Au WY, Chan KW, Lui SL et al. Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. Am J Kidney Dis 1999; 34: 889-893. (Pubitemid 29521706)
8. Perazella MA, Buller GK. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Am J Nephrol 1994; 14: 223-225. (Pubitemid 24257965)
9. Remstein ED, Kurtin PJ, Nascimento AG. Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders. Am J Surg Pathol 2000; 24: 51-55. (Pubitemid 30033396)
10. Mesa RA, Silverstein MN, Jacobsen SJ et al. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol 1999; 61: 10-15. (Pubitemid 29218171)
11. Ańa BJ, Suman VJ, Sobell JL et al. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol 1994; 47: 89-93. (Pubitemid 24302276)
12. Saigusa T, Kikuchi Y, Yamada M et al. A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage. J Nephrol 2006; 19: 656-659. (Pubitemid 46415930)
13. Kosch M, August C, Hausberg M et al. Focal sclerosis with tip lesions secondary to polycythaemia vera. Nephrol Dial Transplant 2000; 15: 1710-1711.
14. Okuyama S, Hamai K, Fujishima M et al. Focal segmental glomerulosclerosis associated with polycythemia vera: report of a case and review of the literature. Clin Nephrol 2007; 68: 412-415. (Pubitemid 350258771)
15. Sharma RK, Kohli HS, Arora P et al. Focal segmental glomerulosclerosis in a patient with polycythemia rubra vera. Nephron 1995; 69: 361.
16. Kaygusuz I, Koc M, Arikan H et al. Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis. Ren Fail 2010; 32: 273-276.
17. Haraguchi K, Shimura H, Ogata R et al. Focal segmental glomerulosclerosis associated with essential thrombocythemia. Clin Exp Nephrol 2006; 10: 74-77.
18. Martyré MC. TGF-beta and megakaryocytes in the pathogenesis of Myelofibrosis in myeloproliferative disorders. Leuk Lymphoma 1995; 20: 39-44. (Pubitemid 3011974)
19. Martyré MC, Magdelenat H, Bryckaert MC et al. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factorbeta in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 1991; 77: 80-86.
20. Reilly JT. Idiopathic myelofibrosis: pathogenesis to treatment. Hematol Oncol 2006; 24: 56-63. (Pubitemid 44023093)
21. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23.
22. Iida H, Seifert R, Alpers CE et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 1991; 88: 6560-6564. (Pubitemid 21914987)
23. Doi T, Vlassara H, Kirstein M et al. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci USA 1992; 89: 2873-2877.
24. Floege J, Burns MW, Alpers CE et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 41: 297-309.
25. Jiang T, Che Q, Lin Y et al. Aldose reductase regulates TGF-beta1-induced production of fibronectin and type IV collagen in cultured rat mesangial cells. Nephrology (Carlton) 2006; 11: 105-112.
26. Okuda S, Languino LR, Ruoslahti E et al. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 86: 453-462. (Pubitemid 20271877)
27. Schiffer M, Bitzer M, Roberts IS et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-816. (Pubitemid 32880291)
28. Wada T, Pippin JW, Terada Y et al. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis. Kidney Int 2005; 68: 1618-1629. (Pubitemid 43169907)
29. Maigne G, Ferlicot S, Galacteros F et al. Glomerular lesions in patients with sickle cell disease. Medicine (Baltimore) 2010; 89: 18-27.
30. Heher EC, Goes NB, Spitzer TR et al. Kidney disease associated with plasma cell dyscrasias. Blood 2010; 116: 1397-1404.
31. Herrera GA, Joseph L, Gu X et al. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med 2004; 128: 875-879. (Pubitemid 39014119)
32. Bridoux F, Hugue V, Coldefy O et al. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. Kidney Int 2002; 62: 1764-1775. (Pubitemid 35286285)
33. Audard V, Larousserie F, Grimbert P et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int 2006; 69: 2251-2260. (Pubitemid 43882113)
34. Moulin B, Ronco PM, Mougenot B et al. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 1992; 42: 127-135.
35. Tefferi A, Thiele J, Orazi A et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092-1097. (Pubitemid 47281402)
36. Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12: 339-351.
37. Murphy S, Iland H, Rosenthal D et al. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 1986; 23: 177-182.
38. D'Agati VD, Jennette JC, Silva FG. Atlas of Nontumor Pathology: Non-Neoplastic Kidney Diseases. American Registry of Pathology-Armed Forces Institute of Pathology: Washington, DC, 2005, pp 269-296.